
News
Home>News & Events>Presentations>PRO Consortium>Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis (RA): The Role of the Patient-Reported Outcome Consortium’s RA Working Group
44
Related Posts
-
Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure
-
PRO Consortium Webinar: Methods for Determining Clinically Meaningful Change
-
Identifying and Measuring the Core Symptoms Reported by Persons with Asthma: A review of the Existing Qualitative Literature and Patient-Reported Outcome Measures
-
Development of the Initial Version of the Asthma Daily Symptom Diary
-
Assessing the translatability of a new patient-reported outcome measure for Major Depressive Disorder